Journey Medical Corp Proceeds from Long-term Lines of Credit
Journey Medical Corp (DERM) reported Proceeds from Long-term Lines of Credit of $10.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-03-26
- Journey Medical Corp proceeds from long-term lines of credit for the quarter ending 2024-12-31 was $5.05M.
- Journey Medical Corp proceeds from long-term lines of credit for the quarter ending 2024-09-30 was -$50.00K.
- Journey Medical Corp proceeds from long-term lines of credit for the quarter ending 2022-12-31 was $0.00.
- Journey Medical Corp proceeds from long-term lines of credit for the quarter ending 2022-09-30 was $5.00M.
- Journey Medical Corp proceeds from long-term lines of credit for fiscal 2024 was $10.00M, a 33.33% decline from fiscal 2023.
- Journey Medical Corp proceeds from long-term lines of credit for fiscal 2023 was $15.00M, a 24.10% decline from fiscal 2022.
- Journey Medical Corp proceeds from long-term lines of credit for fiscal 2022 was $19.76M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2024-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $5.00M derived: sum of 2 quarters · filed 2026-03-26 | $10.00M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.95M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $5.00M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $15.00M 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $5.00M derived: sum of 2 quarters · filed 2024-03-29 | $5.00M derived: sum of 3 quarters · filed 2024-03-29 | $19.76M 10-K · filed 2024-03-29 |
| 2022-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.00M derived: sum of 2 quarters · filed 2023-11-13 | $19.76M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $14.76M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $14.76M 10-Q · filed 2023-05-22 |